BRIEF-AstraZeneca Says Transfer Of Rights To Eklira, Duaklir Completed

BRIEF-AstraZeneca Says Transfer Of Rights To Eklira, Duaklir Completed
Representative Image Image Credit: Twitter (@AstraZeneca)

AstraZeneca PLC:

* ASTRAZENECA PLC - TRANSFER OF RIGHTS TO EKLIRA, DUAKLIR COMPLETED

* ASTRAZENECA - TRANSFER OF GLOBAL RIGHTS FOR EKLIRA AND DUAKLIR TO COVIS PHARMA COMPLETED Source text for Eikon: Further company coverage:

Also Read: BRIEF-AstraZeneca Plc Says Ultomiris Accepted For FDA Priority Review For gMG

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.